切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Ubiquitin-specific proteases - Insulin and Insulin-like Receptors - Eph Receptors - AAT

10 件产品

每页
清除全部
  1. PP121
    B2172 PP121
    Target: mTOR|Eph Receptors|VEGFR|PDGFR|Bcr-Abl|Src|DNA-PK|P110|Hck
    Summary: 酪氨酸激酶和磷酸肌醇激酶双重抑制剂
      ≥15.95 mg/mL
      insoluble in H2O
  2. NVP-BHG712
    A8683 NVP-BHG712
    Target: Eph Receptors|VEGFR
    Summary: EphB4 抑制剂
      ≥25.15 mg/mL
      insoluble in H2O
  3. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  4. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  5. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  6. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O
  7. ALW-II-41-27
    A3165 ALW-II-41-27
     1 Citation
    Target: Eph Receptors
    Summary: Eph受体抑制剂
      ≥102 mg/mL
      insoluble in H2O
  8. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    中文名: 马来酸罗格列酮
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ激动剂,有效的胰岛素敏化剂
      ≥23.7 mg/mL
      insoluble in H2O
  9. P005091
    A3023 P005091
     1 Citation
    Target: Ubiquitin-specific proteases
    Summary: 泛素特异性蛋白酶7(USP7)抑制剂
      ≥17.4 mg/mL
      insoluble in H2O
  10. Atractyloside Dipotassium Salt
    A8188 Atractyloside Dipotassium Salt
     1 Citation
    中文名: 苍术苷钾盐
    Target: AAT
    Summary: AAT抑制剂
      ≥37.05 mg/mL
      ≥110.4 mg/mL

10 件产品

每页